CA
Columbia Advisory Partners LLC
13F filer · CIK 0001808179Reported Jul 23, 2026
Net buyer this quarter
13F portfolio value$181MU.S. long equity reported on 13F
Positions364 new · 1 closed
Net flow last quarter+$141KBuys minus sells
Top 10 positions weight11.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 23, 202636 positions | |||||
| $4.05M | 2.24% | 0.04% | +2.6% | Q2 2025 | |
| $3.14M | 1.73% | 0.00% | -5.0% | Q4 2021 | |
| $2.79M | 1.54% | 0.04% | +5.4% | Q4 2021 | |
| $1.73M | 0.95% | 0.01% | +5.2% | Q4 2022 | |
| $1.7M | 0.94% | 0.00% | +0.5% | Q4 2021 | |
| $1.56M | 0.86% | Not reported | 0.0% | Q3 2025 | |
| $1.43M | 0.79% | 0.00% | -0.8% | Q4 2021 | |
| $1.42M | 0.78% | 0.00% | -0.3% | Q4 2021 | |
| $1.33M | 0.74% | Not reported | -1.1% | Q1 2022 | |
| $1.2M | 0.66% | Not reported | -0.2% | Q1 2022 | |
| $1.09M | 0.60% | 0.01% | -2.4% | Q2 2024 | |
| $955K | 0.53% | 0.00% | +3.9% | Q4 2021 | |
| $603K | 0.33% | 0.00% | -4.7% | Q1 2025 | |
| $544K | 0.30% | 0.01% | Not reported | Q3 2023 | |
| $517K | 0.28% | 0.00% | -0.8% | Q4 2024 | |
| $444K | 0.25% | Not reported | -63.4% | Q4 2021 | |
| $438K | 0.24% | 0.06% | +10.9% | Q2 2025 | |
| $403K | 0.22% | 0.00% | -2.3% | Q4 2024 | |
| $397K | 0.22% | 0.00% | +7.2% | Q4 2021 | |
| $377K | 0.21% | Not reported | -0.9% | Q1 2026 | |
| $368K | 0.20% | 0.00% | -1.6% | Q4 2021 | |
| $330K | 0.18% | 0.00% | +0.6% | Q3 2025 | |
| $304K | 0.17% | 0.00% | Not reported | Q3 2025 | |
| $244K | 0.13% | 0.15% | -7.2% | Q4 2025 | |
| $243K | 0.13% | 0.00% | New | Q2 2026 | |
| $236K | 0.13% | 0.00% | +0.3% | Q4 2022 | |
| $232K | 0.13% | 0.01% | -14.1% | Q4 2025 | |
| $229K | 0.13% | Not reported | +3.4% | Q3 2025 | |
| $227K | 0.13% | 0.00% | New | Q2 2026 | |
| $214K | 0.12% | 0.00% | +5.4% | Q4 2022 | |
| $210K | 0.12% | 0.00% | -5.8% | Q2 2024 | |
| $205K | 0.11% | 0.01% | Not reported | Q2 2024 | |
| $203K | 0.11% | 0.00% | New | Q2 2026 | |
| $187K | 0.10% | 0.02% | +10.4% | Q2 2024 | |
| $15.6K | 0.01% | 0.01% | Not reported | Q1 2025 | |
| $12.6K | 0.01% | 0.05% | Not reported | Q1 2026 | |
| Q1 2026Reported Apr 23, 202633 positions | |||||
| $3.7M | 2.36% | 0.04% | +35.8% | Q2 2025 | |
| $3.14M | 2.00% | 0.03% | -22.9% | Q4 2021 | |
| $2.12M | 1.35% | 0.01% | -23.0% | Q4 2022 | |
| $1.53M | 0.97% | Not reported | +98.3% | Q3 2025 | |
| $1.51M | 0.97% | 0.00% | +1.0% | Q4 2021 | |
| $1.48M | 0.95% | 0.00% | -2.6% | Q4 2021 | |
| $1.43M | 0.91% | Not reported | -11.2% | Q1 2022 | |
| $1.32M | 0.84% | 0.01% | +6.1% | Q2 2024 | |
| $1.25M | 0.80% | 0.00% | +4.2% | Q4 2021 | |
| $1.18M | 0.75% | Not reported | +9.9% | Q1 2022 | |
| $1.16M | 0.74% | Not reported | -9.0% | Q4 2021 | |
| $968K | 0.62% | 0.00% | -3.1% | Q4 2021 | |
| $912K | 0.58% | 0.00% | -2.1% | Q4 2021 | |
| $646K | 0.41% | 0.00% | -8.2% | Q4 2024 | |
| $552K | 0.35% | 0.00% | +38.2% | Q1 2025 | |
| $543K | 0.35% | 0.01% | -22.3% | Q3 2023 | |
| $443K | 0.28% | Not reported | New | Q1 2026 | |
| $350K | 0.22% | 0.16% | +110.9% | Q4 2025 | |
| $344K | 0.22% | 0.00% | +3.1% | Q4 2021 | |
| $332K | 0.21% | 0.00% | -4.7% | Q4 2024 | |
| $325K | 0.21% | 0.00% | -4.7% | Q4 2021 | |
| $322K | 0.21% | 0.00% | -30.2% | Q2 2024 | |
| $312K | 0.20% | 0.01% | +5.4% | Q4 2025 | |
| $290K | 0.18% | 0.00% | +1.7% | Q3 2025 | |
| $281K | 0.18% | 0.06% | +2.5% | Q2 2025 | |
| $271K | 0.17% | 0.00% | +0.9% | Q4 2022 | |
| $246K | 0.16% | 0.00% | -21.1% | Q4 2021 | |
| $208K | 0.13% | Not reported | -7.5% | Q3 2025 | |
| $206K | 0.13% | 0.00% | -3.2% | Q4 2022 | |
| $202K | 0.13% | 0.01% | -0.4% | Q2 2024 | |
| $159K | 0.10% | 0.02% | -28.3% | Q2 2024 | |
| $12.1K | 0.01% | 0.01% | +27.2% | Q1 2025 | |
| $11.9K | 0.01% | 0.05% | New | Q1 2026 | |
| Q4 2025Reported Jan 22, 202636 positions | |||||
| $3.91M | 2.66% | 0.04% | -7.6% | Q4 2021 | |
| $2.75M | 1.87% | 0.03% | +82.5% | Q2 2025 | |
| $2.67M | 1.82% | 0.02% | -12.8% | Q4 2022 | |
| $1.63M | 1.11% | 0.00% | -1.2% | Q4 2021 | |
| $1.34M | 0.91% | Not reported | -4.7% | Q4 2021 | |
| $1.33M | 0.91% | 0.00% | +0.1% | Q4 2021 | |
| $1.31M | 0.89% | Not reported | -9.7% | Q1 2022 | |
| $1.3M | 0.88% | 0.00% | -1.3% | Q4 2021 | |
| $1.22M | 0.83% | 0.00% | -2.4% | Q4 2021 | |
| $1.15M | 0.79% | 0.01% | -34.6% | Q2 2024 | |
| $1.05M | 0.72% | Not reported | -5.2% | Q1 2022 | |
| $844K | 0.58% | 0.00% | -16.7% | Q4 2021 | |
| $777K | 0.53% | 0.01% | -18.8% | Q3 2023 | |
| $770K | 0.52% | Not reported | +52.4% | Q3 2025 | |
| $499K | 0.34% | 0.00% | +0.2% | Q4 2024 | |
| $427K | 0.29% | 0.00% | +9.4% | Q1 2025 | |
| $403K | 0.27% | 0.00% | +8.0% | Q4 2021 | |
| $400K | 0.27% | 0.01% | -3.7% | Q2 2024 | |
| $383K | 0.26% | 0.01% | New | Q4 2025 | |
| $379K | 0.26% | 0.00% | +1.2% | Q4 2024 | |
| $364K | 0.25% | 0.00% | +34.7% | Q4 2021 | |
| $344K | 0.23% | 0.00% | -9.7% | Q3 2025 | |
| $320K | 0.22% | 0.00% | -29.7% | Q4 2021 | |
| $299K | 0.20% | 0.05% | +0.5% | Q2 2025 | |
| $264K | 0.18% | 0.00% | -4.2% | Q4 2022 | |
| $258K | 0.18% | 0.01% | Not reported | Q4 2021 | |
| $245K | 0.17% | 0.00% | New | Q4 2025 | |
| $242K | 0.16% | 0.00% | -12.7% | Q3 2025 | |
| $235K | 0.16% | 0.07% | New | Q4 2025 | |
| $232K | 0.16% | 0.02% | -6.0% | Q2 2024 | |
| $218K | 0.15% | Not reported | Not reported | Q3 2025 | |
| $217K | 0.15% | 0.01% | -6.9% | Q2 2024 | |
| $202K | 0.14% | 0.00% | Not reported | Q4 2022 | |
| $155K | 0.11% | 0.00% | Not reported | Q4 2021 | |
| $15.1K | 0.01% | 0.01% | Not reported | Q1 2025 | |
| BBCABBioAtla, Inc. | $14.8K | 0.01% | 2.05% | Not reported | Q3 2024 |
| Q3 2025Reported Oct 24, 202533 positions | |||||
| $3.39M | 2.34% | 0.05% | -2.7% | Q4 2021 | |
| $2.03M | 1.41% | 0.02% | -2.4% | Q4 2022 | |
| $1.61M | 1.12% | Not reported | +18.6% | Q1 2022 | |
| $1.58M | 1.10% | 0.01% | -5.5% | Q2 2024 | |
| $1.55M | 1.07% | 0.00% | +4.7% | Q4 2021 | |
| $1.48M | 1.02% | 0.02% | +149.9% | Q2 2025 | |
| $1.41M | 0.98% | 0.00% | Not reported | Q4 2021 | |
| $1.41M | 0.97% | Not reported | -9.0% | Q4 2021 | |
| $1.34M | 0.92% | 0.00% | -14.9% | Q4 2021 | |
| $1.27M | 0.88% | 0.00% | -6.8% | Q4 2021 | |
| $1.11M | 0.77% | Not reported | +52.4% | Q1 2022 | |
| $947K | 0.66% | 0.02% | -10.6% | Q3 2023 | |
| $594K | 0.41% | 0.00% | -8.8% | Q4 2021 | |
| $557K | 0.39% | 0.00% | +15.2% | Q4 2021 | |
| $495K | 0.34% | Not reported | New | Q3 2025 | |
| $467K | 0.32% | 0.00% | -5.7% | Q4 2024 | |
| $460K | 0.32% | 0.01% | -7.2% | Q2 2024 | |
| $458K | 0.32% | 0.00% | +78.2% | Q4 2021 | |
| $390K | 0.27% | 0.00% | -21.0% | Q1 2025 | |
| $377K | 0.26% | 0.00% | New | Q3 2025 | |
| $291K | 0.20% | 0.00% | -13.0% | Q4 2024 | |
| $289K | 0.20% | 0.05% | Not reported | Q2 2025 | |
| $274K | 0.19% | 0.00% | +0.5% | Q4 2022 | |
| $270K | 0.19% | 0.02% | -21.1% | Q2 2024 | |
| $268K | 0.19% | 0.00% | -37.2% | Q4 2021 | |
| $253K | 0.17% | 0.01% | -29.6% | Q4 2021 | |
| $237K | 0.16% | 0.00% | New | Q3 2025 | |
| $235K | 0.16% | 0.01% | +11.9% | Q2 2024 | |
| $214K | 0.15% | Not reported | New | Q3 2025 | |
| $211K | 0.15% | 0.00% | New | Q3 2025 | |
| $27.3K | 0.02% | 0.01% | Not reported | Q1 2025 | |
| BBCABBioAtla, Inc. | $17.9K | 0.01% | 0.04% | Not reported | Q3 2024 |
| ATADAPYAdaptimmune Therapeutics PLC | $4.78K | 0.00% | 0.00% | Not reported | Q1 2024 |
Premium opens every quarter this fund has filed